Favipiravir

Duration: 26:05

Write A New Comment

0 Comments

Glenmark's FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet

Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug - Favipiravir with brand name FabiFlu - for the treatment of mild to moderate Covid-19 patients. The firm has become the first Indian company to commercially launch the antiviral drug.

https://www.indiatoday.in/india/story/coronavirus-treatment-drug-glenmark-fabiflu-favipiravir-launch-india-rs-103-per-tablet-reduce-viral-load-1691066-2020-06-20

Coronavirus replication

https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f1/

RdRp is the main enzyme of transcription-replication complex

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322833/

Favipiravir mechanism of action and its study

https://www.biorxiv.org/content/10.1101/2020.05.15.098731v1.full.pdf+html

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

https://www.sciencedirect.com/science/article/pii/S2095809920300631?via%3Dihub

Potential coronavirus drug approved for marketing

Favipiravir, an antiviral that has shown potential in treating the novel coronavirus, was approved for marketing, the Taizhou government of Zhejiang province announced Sunday.

https://www.chinadaily.com.cn/a/202002/17/WS5e49efc2a310128217277fa3.html

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.

https://www.nature.com/articles/d41573-020-00016-0

Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production

https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html

In this video, Dr. Mobeen will discuss:

1. Studies regarding favipiravir. (2:13)

2. Mechanism of action of favipiravir. (8:15)

3. Important facts about favipiravir. (14:20)

4. End effect of favipiravir. (22:28)

Presented by Dr. Mobeen Syed

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.